Letter to NeuroscienceEndothelial expression of the 5-hydroxytryptamine1B antimigraine drug receptor in rat and human brain microvessels
Section snippets
Acknowledgements
These studies were supported by grants to L.D. and to E.H. from the Medical Research Council of Canada, and to M.H. from INSERM. The authors are also grateful to Dr André Olivier (Montreal Neurological Institute) for providing the human tissue specimens, to Kenneth C. Watkins for expert technical assistance, and to Isabelle Bouchelet for comments on the manuscript.
References (28)
- et al.
The mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals
Neuroscience
(1994) - et al.
Localization of 5-HT1B, 5-HT1Dα, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain
Neuropharmacology
(1994) - et al.
Serotonin in the regulation of brain microcirculation
Prog. Neurobiol.
(1996) - et al.
Differential addressing of 5-HT1A and 5-HT1B receptors in transfected LLC-PK1 epithelial cells: a model of receptor targeting in neurons
Neuroscience
(1996) - et al.
Light and electron microscopic immunocytochemical visualization of 5-HT1B receptors in the rat brain
Brain Res.
(1997) - et al.
The uptake and fate of the radiolabeled 5-hydroxytryptamine in isolated cerebral microvessels
Brain Res.
(1981) - et al.
Expression of serotonin receptor mRNAs in blood vessels
Fedn Eur. biol. Socs Lett.
(1995) - et al.
5-HT1D receptors in the guinea pig brain: pre- and postsynaptic localizations in the striatonigral pathway
Brain Res.
(1990) - et al.
Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels
Molec. Pharmac.
(1996) - et al.
Biochemical and pharmacological characterization of serotonin-O-carboxymethylglycyl-[125I]iodotyrosinamide, a new radioiodinated probe for 5-HT1B and 5-HT1D binding sites
J. Neurochem.
(1992)
High-affinity binding of [3H]paroxetine to caudate nucleus and microvessels from porcine brain
NeuroReport
Regulation of regional blood flow in cerebral cortex by serotonergic neurons originating in the dorsal raphe nucleus in the rat
Biogen. Amines
Expression of 5-HT1Dβ, 5-HT1F, 5-HT2B, 5-HT2C and 5-HT7 receptor mRNAs in human intraparenchymal microvessels and related cells in culture
Soc. Neurosci. Abstr.
In situ hybridization evidence for the synthesis of 5-HT1B receptor in serotoninergic neurons of anterior raphe nuclei in the rat brain
Synapse
Cited by (41)
Central 5-HT receptors and their function; present and future
2020, NeuropharmacologyCitation Excerpt :At the macro-level, 5-HT receptors are widely distributed, with specific brain regions having distinct complements of 5-HT receptor subtypes: for instance, cortical and limbic areas - 5-HT1A, 5-HT2A/C, 5-HT3, 5-HT4, 5-HT6; basal ganglia - 5-HT1B, 5-HT2A/C, 5-HT4, 5-HT6; mesolimbic pathways - 5-HT1B, 5-HT2A/C, 5-HT4 receptors; hypothalamus (eg. paraventricular and arcuate nuclei) - 5-HT2C; suprachiasmatic nucleus - 5-HT7; trigeminal nucleus - 5-HT1B/D/F; dorsal vagal complex (encompassing the area postrema and nucleus tractus solitarus, and dorsal motor nucleus of the vagus nerve) - 5-HT3. The majority of data favour 5-HT receptors being principally expressed by neurons; evidence that they are expressed by non-neural cells is often conflicting with the possible exception of cells of the cerebrovasculature, especially as in the case of the 5-HT1B receptor (Parsons, 1991; Riad et al., 1998). In particular, the literature describing the expression of 5-HT receptor subtypes by glial cells is controversial and incomplete.
The barrier, airway particle clearance, placental and detoxification functions of autism susceptibility genes
2016, Neurochemistry InternationalCitation Excerpt :The serotonin precursor 5-hydroxytryptophan (TPH1 TPH2) reinforces the intestinal barrier in healthy controls, but not in patients with irritable bowel syndrome (Keszthelyi et al., 2014). The serotonin receptor (HTR1B) is also involved in the control of vascular permeability in the brain (Riad et al., 1998), while substance P (TAC1) regulates vascular permeability in the intestine, skin and brain (Annunziata et al., 2002; Holzer, 1998; Lordal et al., 1996). Somatostatin is also involved in the control of vascular permeability via SSTR5 and tight junction control (Lei et al., 2014).
Carmustine-loaded catanionic solid lipid nanoparticles with serotonergic 1B receptor subtype antagonist for in vitro targeted delivery to inhibit brain cancer growth
2015, Journal of the Taiwan Institute of Chemical EngineersCitation Excerpt :Moreover, an increase in the S1BRSA concentration promoted the internalization of S1BRSA/BCNU–CASLNs by HBMECs (compared with data shown in Fig. 6(B)). This suggested that grafted S1BRSA could be a promising moiety in intensifying the capacity of S1BRSA/BCNU–CASLNs to deliver BCNU to the brain [95–97]. S1BRSA/BCNU–CASLNs were prepared with catanionic surfactants of TTMAB and SDS for targeting the BBB and inhibiting the growth of malignant GBM U87MG cells.
Delivering etoposide to the brain using catanionic solid lipid nanoparticles with surface 5-HT-moduline
2014, International Journal of PharmaceuticsCitation Excerpt :As exhibited in Fig. 9, an increase in the concentration of 5-HT-moduline enhanced the uptake quantity of 5-HT-moduline/ETP-CASLNs by HBMECs. This evidenced that the modified 5-HT-moduline was a competent surface moiety to improve the transport into HBMECs and could intensify the interaction of 5-HT-moduline with 5-HT1B receptor on HBMECs (Hasegawa et al., 2005; Kaumann and Levy, 2006; Riad et al., 1998). It was worth to note that Fig. 9 was consistent with the data shown in Fig. 8.
5-Hydroxytryptamine receptors in the human cardiovascular system
2006, Pharmacology and Therapeutics